One-year intravenous immunoglobulin replacement therapy: efficacy in reducing hospital admissions in pediatric patients with Inborn Errors of Immunity

CONCLUSION: One-year intravenous IVIG significantly decreased the number of hospitalizations and length of stay in children with impaired antibody production. Social and economic impacts would be required.PMID:34273274 | DOI:10.1016/j.jped.2021.05.011
Source: Jornal de Pediatria - Category: Pediatrics Authors: Source Type: research